Secondary Logo

Journal Logo

Articles by Michael J. Tan, MD, FACP, FIDSA

Telavancin: Another Option, With Caveats

Tan, Michael J.; Written as an editorial commentary regarding Saravolatz et al. A Retrospective Case Series of Telavancin for the Treatment of Staphylococcus aureus Ba

Infectious Diseases in Clinical Practice. 26(5):251, September 2018.